Pulmocare Research And Education Foundation Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 02-12-2024
- Paid Up Capital ₹ 0.10 M
as on 02-12-2024
- Company Age 4 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 107.29%
(FY 2022)
- Profit 131.60%
(FY 2022)
- Ebitda -12.05%
(FY 2022)
- Net Worth 224.14%
(FY 2022)
- Total Assets 147.11%
(FY 2022)
About Pulmocare Research And Education Foundation
The Company is engaged in the Travel And Hospitality Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Sundeep Salvi, Monica Barne, and Sapna Madas serve as directors at the Company.
- CIN/LLPIN
U85300PN2020NPL189936
- Company No.
189936
- Company Classification
Private Not For Profit Company
- Incorporation Date
18 Feb 2020
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Company Details
- Location
Pune, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Pulmocare Research And Education Foundation?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Monica Barne  | Director | 18-Feb-2020 | Current |
| Sundeep Salvi | Director | 18-Feb-2020 | Current |
| Sapna Madas | Director | 18-Feb-2020 | Current |
Financial Performance of Pulmocare Research And Education Foundation.
Pulmocare Research And Education Foundation, for the financial year ended 2022, experienced significant growth in revenue, with a 107.29% increase. The company also saw a substantial improvement in profitability, with a 131.6% increase in profit. The company's net worth Soared by an impressive increase of 224.14%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Pulmocare Research And Education Foundation?
In 2021, Pulmocare Research And Education Foundation had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Chest Research And Training Private LimitedActive 4 years 10 monthsSundeep Salvi, Monica Barne and 1 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Pulmocare Research And Education Foundation?
Unlock and access historical data on people associated with Pulmocare Research And Education Foundation, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Pulmocare Research And Education Foundation, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pulmocare Research And Education Foundation's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
